Serum and mucosal antibody responses to inactivated polio vaccine after sublingual immunization using a thermoresponsive gel delivery system

Intestinal Immunity Is a Determinant of Clearance of Poliovirus After Oral Vaccination

(2014) Peter F. Wright et al.   JOURNAL OF INFECTIOUS DISEASES

Sublingual immunization with a subunit influenza vaccine elicits comparable systemic immune response as intramuscular immunization, but also induces local IgA and TH17 responses

(2014) Simona Gallorini et al.   VACCINE

Safety and Immunogenicity of a Single Oral Dose of Recombinant Double Mutant Heat-Labile Toxin Derived from Enterotoxigenic Escherichia coli

(2013) Samer S. El-Kamary et al.   Clinical and Vaccine Immunology

Antigen sparing with adjuvanted inactivated polio vaccine based on Sabin strains

(2013) Janny Westdijk et al.   VACCINE

A mucosal adjuvant for the inactivated poliovirus vaccine

(2013) Benjamin P. Steil et al.   VACCINE

Hexavalent IPV-based combination vaccines for public-sector markets of low-resource countries

(2013) Kutub Mahmood et al.   Human Vaccines & Immunotherapeutics

Sublingual Delivery of Vaccines for the Induction of Mucosal Immunity

(2013) Byoung-Shik Shim et al.   Immune Network

Vaccines against mucosal infections

(2012) Jan Holmgren et al.   CURRENT OPINION IN IMMUNOLOGY

The A Subunit of Escherichia coli Heat-Labile Enterotoxin Functions as a Mucosal Adjuvant and Promotes IgG2a, IgA, and Th17 Responses to Vaccine Antigens

(2012) Elizabeth B. Norton et al.   INFECTION AND IMMUNITY

Sublingual Immunization with a Live Attenuated Influenza A Virus Lacking the Nonstructural Protein 1 Induces Broad Protective Immunity in Mice

(2012) Hae-Jung Park et al.   PLoS One

The Adjuvant Double Mutant Escherichia coli Heat Labile Toxin Enhances IL-17A Production in Human T Cells Specific for Bacterial Vaccine Antigens

(2012) Susannah Leach et al.   PLoS One

Adjuvants and inactivated polio vaccine: A systematic review

(2012) Jennifer Hawken et al.   VACCINE

Systematic Review of Mucosal Immunity Induced by Oral and Inactivated Poliovirus Vaccines against Virus Shedding following Oral Poliovirus Challenge

(2012) Thomas R. Hird et al.   PLoS Pathogens

Biodegradable Nanoparticles Composed Entirely of Safe Materials that Rapidly Penetrate Human Mucus

(2011) Ming Yang et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

Characterization of a Mutant Escherichia coli Heat-Labile Toxin, LT(R192G/L211A), as a Safe and Effective Oral Adjuvant

(2011) Elizabeth B. Norton et al.   Clinical and Vaccine Immunology

Sublingual mucosa: A new vaccination route for systemic and mucosal immunity

(2011) Mi-Na Kweon   CYTOKINE

Recent advances in the development of novel mucosal adjuvants and antigen delivery systems

(2011) Wangxue Chen et al.   Human vaccines & immunotherapeutics

Sublingual vaccination

(2011) Cecil Czerkinsky et al.   Human vaccines & immunotherapeutics

Safety and Immunogenicity of Inactivated Poliovirus Vaccine Made From Sabin Strains: A Phase II, Randomized, Positive-Controlled Trial

(2011) Guoyang Liao et al.   JOURNAL OF INFECTIOUS DISEASES

Mucosal immunity and poliovirus vaccines: Impact on wild poliovirus infection and transmission

(2011) Hiromasa Okayasu et al.   VACCINE

New insights in mucosal vaccine development

(2011) Vincent Pavot et al.   VACCINE

Options for Inactivation, Adjuvant, and Route of Topical Administration of a Killed, Unencapsulated Pneumococcal Whole-Cell Vaccine

(2010) Y.-J. Lu et al.   Clinical and Vaccine Immunology

Persistence of mucosal and systemic immune responses following sublingual immunization

(2010) Donatella R.M. Negri et al.   VACCINE

Mucosal vaccines: novel advances in technology and delivery

(2009) Yoshikazu Yuki et al.   Expert Review of Vaccines

Suppression of Th1 and Th17, but not Th2, responses in a CD8+ T cell-mediated model of oral tolerance

(2009) PM Arnaboldi et al.   Mucosal Immunology

Toward the development of a stable, freeze-dried formulation of Helicobacter pylori killed whole cell vaccine adjuvanted with a novel mutant of Escherichia coli heat-labile toxin

(2009) Nancy A. Summerton et al.   VACCINE

Oral immunization: an update

(2008) Jiri Mestecky et al.   CURRENT OPINION IN GASTROENTEROLOGY

Preexisting Poliovirus‐Specific IgA in the Circulation Correlates with Protection against Virus Excretion in the Elderly

(2008) Anne‐Marie Buisman et al.   JOURNAL OF INFECTIOUS DISEASES

Identification of the oriI-Binding Site of Poliovirus 3C Protein by Nuclear Magnetic Resonance Spectroscopy

(2008) C. D. Amero et al.   JOURNAL OF VIROLOGY